Martin Zapata Laguado, Medical Oncologist and Internal Medicine Physician at the National Cancer Institute of Colombia, shared a post on X by Juan Pablo Rojas Manrique, Urologist-Oncologist at the University of Cartagena and at Nueva Granada Military University/National Cancer Institute (Colombia), adding:
“Honored to join Juan Pablo Rojas Manrique at the Colombian Society of Urology annual meeting to discuss first-line options in mRCC and the evolving role of dCN and residual disease management in the IO era. Improving the team.”
Quoting Juan Pablo Rojas Manrique’s post:
“Talking about deferred cytoreductive nephrectomy (dCN) at the SCU National Congress, after Martin Zapata Laguado’s great talk on systemic therapy.”
More posts featuring Martin Zapata Laguado.
